文献速递肾癌与肾肿瘤

全州协作组中不确定性肾脏病灶的初始管理:MUSIC-KIDNEY分析

Initial Management of Indeterminate Renal Lesions in a Statewide Collaborative: A MUSIC-KIDNEY Analysis.
PubMed 文献 · J Urol · 2023-03-22

在MUSIC-KIDNEY协作组中,2109例患者有444例(21.1%)初始影像为不确定性肾脏病灶,其中20.0%在90天内接受额外影像,8.3%接受肾脏肿块活检;额外影像使79%病灶重新分类,活检为87%提供明确诊断;33.6%的不确定性病灶接受治疗,未重复影像者良性病理比例高于重复影像者。

要点

  • 21.1%(444/2109)患者初始影像为不确定性肾脏病灶。
  • 额外影像使58.1%重新分类为可疑、21.0%为良性,仅20.9%仍不确定。
  • 33.6%不确定性病灶接受治疗,未重复影像者良性病理比例更高。

核心结论

  • 约33%的不确定性肾脏病灶患者接受立即治疗而未后续影像或肾脏肿块活检,非恶性病理率为10%。

研究设计与样本

  • MUSIC-KIDNEY协作组分析,共2109例患者,444例(21.1%)初始影像为不确定性肾脏病灶。

主要发现

  • 初始影像包括平扫CT 36.2%、增强CT 54.1%、MRI 9.7%。
  • 89例(20.0%)在90天内接受额外影像,37/444(8.3%)接受肾脏肿块活检,16/444(3.6%)接受再影像和活检。
  • 额外影像将58.1%(61/105)重新分类为可疑、21.0%(22/105)为良性,20.9%(22/105)仍不确定;肾脏肿块活检为87%提供明确诊断。
  • 149例(33.6%)不确定性病灶接受治疗,其中117例未再影像、123例未活检。
  • 手术病理良性比例:未重复影像者9.9% vs 重复影像者6.7%;≤4 cm病灶中分别为11.8% vs 4.3%。

临床怎么用

  • 作者认为,对于cT1肾脏肿块,手术前应确认病灶基于高质量多期横断面影像和/或组织病理学特征为可疑肾细胞癌,即使需要后续随访影像和/或肾脏肿块活检。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Renal masses can be characterized as "indeterminate" due to lack of differentiating imaging characteristics. Optimal management of indeterminate renal lesions remains nebulous and poorly defined. We assess management of indeterminate renal lesions within the MUSIC-KIDNEY (Michigan Urological Surgery Improvement Collaborative-Kidney mass: Identifying and Defining Necessary Evaluation and therapY) collaborative. MATERIALS AND METHODS: Each renal mass is classified as suspicious, benign, or indeterminate based on radiologist and urologist assessment. Objectives were to assess initial management of indeterminate renal lesions and the impact of additional imaging and biopsy on characterization prior to treatment. RESULTS: Of 2,109 patients, 444 (21.1%) had indeterminate renal lesions on their initial imaging, which included CT without contrast (36.2%), CT with contrast (54.1%), and MRI (9.7%). Eighty-nine patients (20.0%) underwent additional imaging within 90 days, 8.3% (37/444) underwent renal mass biopsy, and 3.6% (16/444) had reimaging and renal mass biopsy. Additional imaging reclassified 58.1% (61/105) of indeterminate renal lesions as suspicious and 21.0% (22/105) as benign, with only 20.9% (22/105) remaining indeterminate. Renal mass biopsy yielded a definitive diagnosis for 87%. Treatment was performed for 149 indeterminate renal lesions (33.6%), including 117 without reimaging and 123 without renal mass biopsy. At surgery for indeterminate renal lesions, benign pathology was more common in patients who did not have repeat imaging (9.9%) than in those who did (6.7%); for ≤4 cm indeterminate renal lesions, these rates were 11.8% and 4.3%. CONCLUSIONS: About 33% of patients diagnosed with an indeterminate renal lesion underwent immediate treatment without subsequent imaging or renal mass biopsy, with a 10% rate of nonmalignant pathology. This highlights a quality improvement opportunity for patients with cT1 renal masses: confirmation that the lesion is suspicious for renal cell carcinoma based on high-quality, multiphase, cross-sectional imaging and/or histopathological features prior to surgery, even if obtaining subsequent follow-up imaging and/or renal mass biopsy is necessary. When performed, these steps lead to reclassification in 79% and 87% of indeterminate renal lesions, respectively.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Butaney M, Wilder S, Patel AK, et al. Initial Management of Indeterminate Renal Lesions in a Statewide Collaborative: A MUSIC-KIDNEY Analysis. J Urol. 2023. PMID: 36947795. doi:10.1097/JU.0000000000003433

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。